Remy Luthringer - Feb 16, 2022 Form 4 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role
CEO, Director
Signature
/s/ Ryan Sansom, Attorney-in-Fact
Stock symbol
NERV
Transactions as of
Feb 16, 2022
Transactions value $
$0
Form type
4
Date filed
2/18/2022, 03:33 PM
Next filing
Dec 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NERV Employee Stock Option (right to buy) Award $0 +505K $0.00 505K Feb 16, 2022 Common Stock 505K $0.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter.